Sergio Traversa, CEO of Relmada Therapeutics RLMD, has filed 14 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $712.8K. The latest trade was on 25/12/15.

ST

ST

Sergio Traversa

CEO

Company

Relmada Therapeutics RLMD

First filing

23/05/30

Trades

20 trades

Buys / sales

14 / 0

12-month net buying

$712.8K

Last trade

25/12/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Relmada TherapeuticsRLMD	Open-market buy	25/12/15	25/12/16	27,500 sh	$4.12	$113,300	+2.2%
Relmada TherapeuticsRLMD	Open-market buy	25/11/05	25/11/06	272,500 sh	$2.20	$599,500	+27.3%
Relmada TherapeuticsRLMD	Open-market buy	25/08/26–25/08/28	25/08/28	265,976 sh3 trades	$0.67avg.	$178,094.99	+36.2%
Relmada TherapeuticsRLMD	Open-market buy	25/05/16–25/05/20	25/05/20	350,000 sh3 trades	$0.50avg.	$175,245.46	+91.1%
Relmada TherapeuticsRLMD	Open-market buy	24/09/09–24/09/11	24/09/11	140,000 sh3 trades	$2.82avg.	$395,114.52	+57.4%
Relmada TherapeuticsRLMD	Open-market buy	24/01/29–24/01/31	24/01/31	100,000 sh3 trades	$3.87avg.	$386,753.21	+69.4%